Numerous developmental changes in the nervous system occur during the first several 35 weeks of the rodent lifespan. Therefore many characteristics of neuronal function described at 36 the cellular level from in vitro slice experiments conducted during this early time period may not 37 generalize to adult ages. We investigated the effect of dopamine on inhibitory synaptic 38 transmission in superficial layers of the medial prefrontal cortex in prepubertal (P12-20), 39 periadolescent (P30-48), and adult (P70-100) mice. The prefrontal cortex is associated with 40 higher-level cognitive functions such as working memory and is associated with initiation, 41 planning and execution of actions as well as in motivation and cognition. It is innervated by 42 dopamine releasing fibers that arise from the ventral tegmental area. In slices from prepubertal 43 mice, dopamine produced a biphasic modulation of inhibitory synaptic currents (IPSCs) recorded 44 in layer II/III pyramidal neurons. Activation of D2-like receptors leads to an early suppression of 45 the evoked IPSC, which was followed by a longer-lasting facilitation of the IPSC mediated by 46 D1-like dopamine receptors. In periadolescent mice, the D2 receptor-mediated early suppression 47 was significantly smaller compared to the prepubertal animals, and absent in adult animals. 48 Furthermore, we found significant differences in the dopamine-mediated lasting enhancement of 49 the inhibitory response between the developmental groups. Our findings suggest that behavioral 50 paradigms that elicit dopaminergic release in the prefrontal cortex differentially modulate 51 inhibition of excitatory pyramidal neuron output in prepuberty compared to periadolescence and 52 adulthood in the superficial layers (II/III) of cortex. 53 54 2007). This region appears to play a role in the initiation, planning and execution of various 72 actions, motivation and cognition (Goldman-Rakic et al. 1989; Egan and Weinberger 1997; 73 Seamans and Yang 2004). Impairment of the PFC has been associated with a number of 74 neurological and psychiatric disorders. The PFC is richly innervated by DA-containing fibers 75 arising from the ventral tegmental area. In this study, we investigated the influence of DA on 76 inhibitory synaptic transmission in mPFC supragranular pyramidal neurons (layers II/III) from 77 three distinct ages: prepubertal (postnatal age: 12-20 days), periadolescent (postnatal age: 30-48 78 157 drug, drug (DA or agonist), wash. Statistical analyses of drug effect vs. predrug control were 158 done using a paired t-test. For comparison across age groups, the evoked responses were 159 compared between the prepubertal (P12-20) and periadolescent (P30-48) groups within an 160 "early" time period (7-15 min) and "late" time period (18 to 28 min). Differences between the 161 different age groups during the distinct early or late time periods were assessed using a two-way 162 ANOVA with Tukey-Kramer multiple comparisons test. All data are presented as mean±SEM 163 unless noted otherwise. P-values <0.05 was considered statistically significant in all cases. 164 165
INTRODUCTION
Numerous developmental changes in the nervous system occur during the first several 57 weeks in rodents (Andersen et The prefrontal cortex (PFC) is typically associated with higher-level cognitive functions 70 such as working memory and executive decisions (Seamans and Yang 2004 ; O'Grada and Dinan 71 days), and adult (postnatal age: 70-100 days). The PFC, like other cortical areas, contains 79 multiple subtypes of GABAergic inhibitory neurons that send their projections to different layers 80 within the cortex and may provide functionally distinct forms of inhibition (Kawaguchi and 81 Kondo 2002; Xu and Callaway 2009 ). Therefore, we tested if DA indiscriminately modulated 82 inhibitory processes via distinct pathways. In this study we stimulated distinct inhibitory inputs 83 to the pyramidal neuron by selectively stimulating layer I fibers as well as local inhibitory inputs 84 (Gabbott and Somogyi 1986; Cauller and Connors 1994) . 85
Our investigations found that an early suppression of inhibitory synaptic currents due to 86 D2 receptor activation occurred in prepubertal animals, but not in periadolescent and adult 87 animals. In addition, the magnitude of a late onset facilitation of inhibition due to D1 receptor 88 activation was significantly greater in the prepubertal group. We also found significant 89 differences in the magnitude of DA-mediated actions depending on the pathway of stimulation. 90
These findings indicate that DA produces complex biphasic modulation of inhibitory synaptic 91 transmission in layer II/III pyramidal neurons of prefrontal cortex that is modified over 92 development from prepuberty to adolescence. 93
94

METHODS
95
All experimental procedures were carried out in accordance with the National Institute of 96 Health guidelines and approved by the University of Illinois Animal Care and Use Committee. 97
Mice (FVB, postnatal age: 12-20 (prepubertal), 30-48 (periadolescent) and 70-100 (adult) days 98 were deeply anesthetized with sodium pentobarbital (50 mg/kg) and decapitated. The brain was 99 quickly removed and placed into cold, oxygenated slicing medium containing (in mM): 2.5 KCl, 100 10.0 MgCl 2 , 0.5 CaCl 2 , 1.25 NaH 2 PO 4 , 26.0 NaHCO 3 , 11.0 glucose, and 234.0 sucrose. Tissue 101 slices (300 μm thickness) were cut in the coronal plane using a vibrating tissue slicer, transferred 102 to a holding chamber, and incubated for at least one hour before recording. Individual slices were 103 transferred to a submersion-type recording chamber on a modified microscope stage and 104 continuously superfused with oxygenated physiological saline at 32 °C. A low power objective 105 (5x) was used to identify layers II/III of mPFC and a high power water-immersion objective 106 (63x) was used to visualize individual pyramidal neurons. The physiological solution used in the 107 experiments contained (in mM): 126.0 NaCl, 2.5 KCl, 1.25 MgCl 2 , 2.0 CaCl 2 , 1.25 NaH 2 PO 4 , 108 26.0 NaHCO 3 , and 10.0 glucose. This solution was gassed with 95% O 2 /5% CO 2 to a final pH of 109 7.4. 110
Whole-cell recordings were obtained with the visual aid of a modified Axioskop 2FS 111 microscope equipped with infrared differential interference contrast optics (Zeiss Instruments, 112
Thornwood NY). Recording pipettes had tip resistances of 3-6 MΩ when filled with an 113 intracellular solution containing (in mM): 117 K-gluconate, 13 KCl, 1.0 MgCl 2 , 0.07 CaCl 2 , 0.1 114 EGTA, 10.0 HEPES, 2.0 Na 2 -ATP, 0.4 Na-GTP, and 0.3% biocytin for evoked inhibitory 115 responses. For recordings of spontaneous and miniature inhibitory currents, Cs + was substituted 116 for K + in the recording pipette. The pH was adjusted to 7.3 using CsOH (or KOH) and the osmolarity was adjusted to 290-300 mosm. The initial access resistance ranged from 10 to 25 118 MΩ and remained stable during the recordings included for analyses. 119 A Multiclamp 700 amplifier (Molecular Devices, Foster City, CA) was used in voltage 120 clamp mode for current recordings. Voltage and current protocols were generated using pClamp 121 software (Molecular Devices) and data were stored on computer. In current-clamp recordings, an 122 active bridge circuit was continuously adjusted to balance the drop in potential produced by 123 passing current through the recording electrode. The apparent input resistance was calculated 124 from the linear slope of the voltage current relationship near rest obtained by applying constant 125 current pulses ranging from -100 pA to +40 pA (500 ms duration). 126
Stimulating electrodes were placed in layer I (S1) and deep layers (layers V/VI: S2) and 127 synaptic responses were evoked with constant current pulses (50-400 μA, 100 μs). All evoked 128 and spontaneous inhibitory postsynaptic currents (IPSCs) were recorded in the presence of 129 NMDA and non-NMDA glutamate receptor antagonists, CPP (10 μM) and DNQX (20 μM), 130 respectively. In order to obtain isolated layer I stimulation, a scalpel was used to make an 131 incision perpendicular to the pial surface just below the layer I border through the underlying 132 white matter (Cauller and Connors 1994) . The stimulating electrode was placed in layer I on 133 opposite side of the transection from the recording electrode. This preparation, in conjunction 134 with glutamate receptors antagonists, ensure that a monosynaptic inhibitory pathway is obtained 135 between the stimulating electrode and the recording electrode via layer I. Stimuli to layer I (S1) 136 or deep layers (S2) were alternatively delivered at 10 s intervals. 137
Agonists were applied by injecting a bolus into the input line of the chamber using a 138 motorized syringe pump. Based on the rates of drug injection and chamber perfusion, the final 139 bath concentration of the agonist was estimated to be one-fourth of the concentration introduced into the flow line (Cox et al. 1995) . All concentrations with the manuscript refer to final bath 141 concentration. Control injections of physiological saline did not alter the membrane potential or 142 input resistance indicating that the temporary increase in flow rate during bolus injection had no 143 effect on the recordings. DA was prepared with 0.08% ascorbic acid to prevent oxidation and 144 this mix was made fresh every 2-3 hours during the course of the experiment. All antagonists 145 were bath applied. All chemicals were obtained from Tocris (St. Louis, MO). Layer I stimulation (S1)
In a representative pyramidal neuron recorded from a prepubertal animal (P13), bath 188 application of DA (50 μM, 4 min) produced an initial suppression of the IPSC evoked by S1 189 stimulation that recovered within 5 minutes ( Fig. 1Ai , ii left). In contrast, in a pyramidal neuron 190 from an older animal (P45), DA produced minimal alteration of the IPSC (Fig 1Ai, ii, right) . 
Deep layer stimulation (S2): 212
A second stimulating electrode was placed in the subgranular layers near underlying 213 white matter (S2). As shown in figure 1Bi in a neuron from a P13 animal, DA produced an initial 214 suppression followed by a longer lasting facilitation of the IPSC. In a representative neuron from 215 the P30-48 group, DA only produced a lasting facilitation of the IPSC (Fig. 1Bi, ii, right) . In the 216 P12-20 group, DA significantly suppressed the IPSC during the early phase to 83.6±5.3% control 217 (n=9, P<0.05, paired t-test), which was followed by a significant, longer-lasting facilitation of 218 the IPSC (123.2±8.9% control, P<0.05, n=9, paired t-test). In neurons from the P30-48 group, 219 the IPSC was unchanged during the early phase (100.9±4.3% control, n=9, p>0.1, paired t-test), 220 but significantly facilitated during the late phase (114.0±6.0% control, P<0.05, n=9, paired t-221 test). Between age groups, the effects of DA during the early phase significantly differed 222 between the age groups (Fig. 1Biii, P<0 .05, F 1,8 =79.4, two-way ANOVA); however, the 223 facilitation of the IPSC during the late phase did not significantly differ (P>0.1, F 1, 8 =0.09, two-224 way ANOVA). 225
As observed with S1 stimulation, the DA-mediated suppression of the IPSC did not alter 226 paired pulse depression, which is consistent with a postsynaptic site of action. In neurons from 227 younger animals, paired pulse depression was unaltered during the early phase (Pre-drug: We next analyzed if the magnitude and/or direction of DA-mediated effect on the IPSC 236 differed depending on the stimulation site, superficial (S1) versus subgranular (S2) stimulation. 237
In the P12-20 group, the DA-mediated early suppression of the IPSC evoked by S1 and S2 238 stimulation did not significantly differ from each other (P>0.05, F 1,8 =3.61, two-way ANOVA). 239
In contrast, the DA-mediated facilitation of the IPSC during the late phase significantly differed 240 between stimulation sites (P<0.05, F 1,8 =4.55, two-way ANOVA). In the P30-48 group, both 241 early phase attenuation (P<0.05, F 1,8 =17.43, two-way ANOVA) and late phase enhancement 242 (P<0.05, F 1, 8 =4.8, two-way ANOVA) of the IPSC by DA significantly differed between 243 stimulation sites. 244
245
D2-receptor mediated suppression of inhibition 246
S1 stimulation: 247
As illustrated by a neuron from a prepubertal animal (P17), the selective D2 receptor 248 agonist quinpirole (10 μM) produced a reversible, suppression of the IPSC ( Fig. 2A i, ii left) . In a 249 neuron from a P43 animal, quinpirole (10 μM) produced a smaller initial suppression of the 250 IPSC ( Fig. 2Ai, ii right) . In the overall population, quinpirole significantly attenuated the IPSC 251 to 89.5±1.7% control (n=12, P<0.05, paired t-test), but there was no corresponding significant 252 reduction in the P30-48 group (Fig. 2Aiii ). During the early phase, there was a significant 253 difference between the P12-20 and P30-48 groups (Fig. 2Aiii, P<0 .05, F 1,7 =20.77, two-way 254 ANOVA). While the reduction in the IPSC was long lasting and slowly returned to control 255 levels, we found no significant difference between the quinpirole responses and control during 256 the late phase ( Fig. 2iii) . 257 258 S2 stimulation: 259
In the same neuron from the P17 animal above, quinpirole produced a similar attenuation 260 in the S2 evoked IPSC amplitude that eventually returned to control levels ( Fig. 2A i and ii, left) . 261
In the neuron from the P43 animal, the IPSC was unaltered by quinpirole (2Ai, ii, right). Overall, 262 quinpirole (10 μM) significantly reduced the IPSC amplitude to 94.3±1.7% control (n=12, 263 P<0.05, paired t-test) in the P12-20 group, but there was no significant change in the P30-48 264 group. As predicted, during the early and late phase, attenuation of the IPSC produced by 265 quinpirole in the P12-20 group was significantly different from that in the P30-48 group (Fig.  266 2Biii, 7-15 min: P<0.05, F 1,7 =34; 19-28 min: P<0.05, F 1,7 =8.31, two-way ANOVA). 267 268 S1 vs. S2 stimulation: 269
We next compared the effect of stimulus location on quinpirole response within the two 270 groups. In the P12-20 group, S1 stimulation produced a significantly greater attenuation of the 271 IPSC during the early phase (7-15 min) compared to S2 stimulation (n=12, P<0.05, F 1,7 =4.38, 272 two-way ANOVA). While the peak reductions are similar during the early phase, the suppression 273 onset occurs earlier with S2 stimulation. 274
275
D1-receptor mediated facilitation of inhibition 276
S1 stimulation: 277
We next tested the influence of the selective D1 agonist SKF38393 on the evoked IPSCs. 278
In a neuron from a P16 animal, SKF38393 (10 μM) produced a long latency enhancement of the 279 IPSC that reached peak magnitude about 25 minutes post-DA (Fig. 3Ai, ii left) . In the population 280 data, SKF38393 produced a facilitation of the IPSC significantly greater than control levels 281 during the late phase (138.4±9.0% control, n=7, P<0.05, paired t-test), but not during the early 282 phase ( Fig. 3Aiii; 103 .3±4.6% control, n=7, P>0.1, paired t-test). In a representative neuron from 283 an older animal (P36), SKF38393 produced a small enhancement of the IPSC (Fig. 3Bi, ii right) . 284
The small enhancement was significantly greater than baseline during the early phase 285 During the early phase, the facilitation of the IPSC by SKF38393 was significantly 293 greater in P30-48 animals than in P12-20 animals (Fig. 3Aiii, P<0 .05, F 1,7 =7.32, two-way 294 ANOVA), whereas during the late phase the facilitation of IPSC by SKF38393 was significantly 295 greater in the P12-20 group (P<0.05, F 1,7 =29.57, two-way ANOVA). 296
297
S2 stimulation: 298
Similar to the S1 stimulation, SKF38393 produced a long-latency facilitation of the IPSC 299 in the P12-20 group, whereas in the P30-48 group, there was a smaller magnitude, early enhancement of the IPSC, which remained stable throughout the recording (Fig. 3Bi, ii) . In the 301 P12-20 group, SKF38393 produced a significant facilitation of the IPSC magnitude during the 302 early phase (Fig. 3Biii, 112 .1±3.7% control, n=7, P<0.05, paired t-test), which was further 303 enhanced during the late phase (135.4±7.5% control, n=7, P<0.05, paired t-test). In the P30-48 304 group, SKF38393 produced a significant enhancement during the early phase (119.8±6.1% 305 control; n=5, P<0.05, paired t-test), but unlike the P12-20 group, this enhancement remained 306 stable during the late phase, (120.0±7.2% control, n=5, P<0.05, paired t-test). 307
In the P12-20 group, the paired pulse ratios were reduced by SKF38393 in both early 308 phase (Pre-drug: 0.82±0.02, SKF38393: 0.76±0.02, P<0.05, n=7, paired t-test) and late phase 309 During the early phase, the magnitude of the DA-mediated facilitation of the IPSC in the 314 P30-48 group was significantly greater than the P12-20 group (P<0.05, F 1,7 =9.42, two-way 315 ANOVA). During the late phase, the facilitation of the IPSC in P12-20 group was significantly 316 greater than the P30-48 group (n=7, P<0.05, F 1,7 =8.91, two-way ANOVA). 317 318 S1 vs. S2 stimulation: 319
When comparing the affect of SKF38393 on the IPSCs evoked by S1 and S2 stimulation, 320 we found that in the early phase, the P30-48 group showed significant differences between the 321 two different stimuli (P<0.02, F 1,7 =5.4, two-way ANOVA), but no difference was observed in 322 the P12-20 group. Similarly, in the late phase, the P30-48 group showed significant difference in responses evoked by the different stimulus locations (n=5, P<0.05, F 1,7 =9.8, two-way ANOVA) 324 but was not significant in the P12-20 group. 325 326
Actions of dopamine in adult mice 327
We further recorded evoked IPSCs in 9 cells from adult mice (P70 -P100). In 4 of 9 328 cells, DA produced no effect on the evoked IPSC in either the 'early' or 'late' phase. In the other 329 5 neurons, DA produced no change during the 'early' phase but a significant enhancement of the 330 IPSC during the late phase. In a representative pyramidal neuron (P93), DA (50 μM, 4 min) 331 produced negligible initial suppression during the early phase with S1 stimulation followed by a 332 small increase in IPSC amplitude during the late phase 333
( Figure 4A, B) . Overall, in the P70-100 group, DA did not alter the evoked IPSC in the early 334 phase ( Fig. 4C; 98 .0±5.4% control, n=5, P>0.05, paired t-test). During the late period, the IPSC 335 amplitude was significantly facilitated to 112.0±5.0% control (P<0.05, n=5, paired t-test). With 336 deep layer (S2) stimulation we observed a similar pattern as with S1 stimulation (Fig. 4A, B) . 337 DA did not alter the IPSC amplitudes during the early phase ( Fig. 4C ; 100.5±1.7% control, 338 P>0.05, n=5, paired t-test) but IPSC amplitude was significantly enhanced during the late phase 339 (112.1±2.7 %, P<0.05, n=5, paired t-test). These results are similar to that obtained in 340 periadolescent mice (P30-48) and show that the reduction of the D2 receptor mediated inhibition 341 seen in periadolescent mice is also seen in adult mice. 342
343
DA enhances miniature IPSC activity 344
In our experiments with evoked stimuli we found that the early phase reduction of evoked 345 animals. The early suppression could then be followed by a longer lasting facilitation of the 347 IPSC, which was more evident with S2 stimulation. Our experiments using paired pulse stimuli 348 revealed that DA did not alter paired pulse ratios during the suppression, suggesting this effect 349 does not involve a presynaptic component. As an additional approach to investigate potential minutes post DA application and returned to baseline within 30 minutes (Fig. 5A, B ). In this 357 particular neuron, mIPSC frequency was increased from 8.4 Hz to 10.9 Hz and mIPSC amplitude 358 from 22.8 pA to 26.3 pA (Fig. 5B ). In the overall population, DA significantly increased mIPSC 359 frequency from 10.8±1.0 Hz to 13.8±1.5 Hz (n=8, P<0.0001, Kolmogorov-Smirnov (K-S) test) 360 and mIPSC amplitude from 21.2±1.2 pA to 22.8±1.3 pA (n=8, P<0.0001, K-S test). These data 361 suggest that DA increases GABA release from presynaptic axon terminals in the absence of 362 presynaptic interneuron activity. However, this appears to be separate from the mechanism 363 underlying the DA-mediated suppression of the IPSC during the early phase since we did not 364 observe a reduction of mIPSC frequency or amplitude. 365
In a representative neuron, the D1-like receptor agonist SKF38393 (20 μM) significantly 366 increased the mIPSC frequency from 7.4 to 9.1 Hz (Fig. 6A, P<0 Fig. 6D ). These data suggest that the D1-like 371 receptors are involved in the enhancement of mIPSC activity in mPFC pyramidal neurons. In 372 contrast, the D2-like receptor agonist quinpirole (20 μM) did not alter the mIPSC activity in 373 mPFC pyramidal neurons (n=3). 374
Considering SKF38393 enhanced mIPSC activity, we next tested the sensitivity of the 375 DA-mediated changes to the selective D1 antagonist SCH23390. In the presence of SCH23390 376 (3 μM), DA (100 μM) did not alter mIPSC activity (Fig. 7A, B ). In the population data ( Fig. 7Di,  377 ii), the frequency and amplitude of mIPSCs remained unchanged from control levels (frequency: 378 n=5, P=0.6, K-S test; amplitude: n=5, P=0.3, K-S test). This is in striking contrast to the robust 379 increase in mIPSC activity produced by DA (c.f., Fig. 5 ). These data indicate that the increase in 380 mIPSC activity is mediated by D1 receptors. Our data suggests that the presynaptic modulation 381 of GABA by DA in these neurons is due to alterations in D1 mediated release and is separate 382 from the mechanism that produces a decrease in evoked IPSC due to D2 receptor action in 383 prepubertal mice. 384
385
DISCUSSION
386
In this study we observed age-related alterations in dopaminergic modulation of synaptic 387 transmission in layer II/III mPFC pyramidal neurons of mice. We also investigated potential 388 differential actions of DA modulation on IPSCs due to distinct afferent inhibitory pathways on 389 the pyramidal neurons. Our results show that in prepubertal animals (P12-20), DA produces an 390 early suppression of the IPSC via activation of D2 receptors. This suppressive action is minimal 391 or absent in periadolescent mice (P32-48). In recordings from adult animals (P70-100), the 392 suppressive action of DA was absent, similar to that observed in periadolescent animals. Overall, our data indicate not only that DA produces complex actions on inhibitory activity on 400 mPFC neurons, but through development these actions change as well. 401
402
D2 mediated suppression of IPSC 403
A primary finding of this study is that there are significant differences in DA-mediated 404 modulation of inhibitory synaptic neurotransmission between prepubertal and periadolescent 405 mice in layer II/III pyramidal neurons of the mPFC. As is with most in vitro brain slice studies 406 
